The dominant‐negative effect of the Q218K variant of the prion protein does not require protein X
- 1 October 2007
- journal article
- Published by Wiley in Protein Science
- Vol. 16 (10) , 2166-2173
- https://doi.org/10.1110/ps.072954607
Abstract
Previous studies identified several single-point mutants of the prion protein that displayed dominant-negative effects on prion replication. The dominant-negative effect was assumed to be mediated by protein X, an as-yet-unknown cellular cofactor that is believed to be essential for prion replication. To gain insight into the mechanism that underlies the dominant-negative phenomena, we evaluated the effect of the Q218K variant of full-length recombinant prion protein (Q218K rPrP), one of the dominant-negative mutants, on cell-free polymerization of wild-type rPrP into amyloid fibrils. We found that both Q218K and wild-type (WT) rPrPs were incorporated into fibrils when incubated as a mixture; however, the yield of polymerization was substantially decreased in the presence of Q218K rPrP. Furthermore, in contrast to fibrils produced from WT rPrP, the fibrils generated in the mixture of WT and Q218K rPrPs did not acquire the proteinase K-resistant core of 16 kDa that was shown previously to encompass residues 97-230 and was similar to that of PrP(Sc). Our studies demonstrate that the Q218K variant exhibits the dominant-negative effect in cell-free conversion in the absence of protein X, and that this effect is, presumably, mediated by physical interaction between Q218K and WT rPrP during the polymerization process.Keywords
This publication has 20 references indexed in Scilit:
- Inhibition of PrPSc formation by lentiviral gene transfer of PrP containing dominant negative mutationsJournal of Cell Science, 2004
- Probing the instabilities in the dynamics of helical fragments from mouse PrP CProceedings of the National Academy of Sciences, 2004
- Non-glycosylphosphatidylinositol (GPI)-anchored recombinant prion protein with dominant-negative mutation inhibits PrPScreplicationin vitroAmyloid, 2004
- Autocatalytic Conversion of Recombinant Prion Proteins Displays a Species BarrierJournal of Biological Chemistry, 2004
- Dominant-negative inhibition of prion replication in transgenic miceProceedings of the National Academy of Sciences, 2002
- Acridine and phenothiazine derivatives as pharmacotherapeutics for prion diseaseProceedings of the National Academy of Sciences, 2001
- Elimination of prions by branched polyamines and implications for therapeuticsProceedings of the National Academy of Sciences, 1999
- Evidence for protein X binding to a discontinuous epitope on the cellular prion protein during scrapie prion propagationProceedings of the National Academy of Sciences, 1997
- Association between natural scrapie and PrP genotype in a flock of Suffolk sheep in ScotlandVeterinary Record, 1997
- Amino acid polymorphisms of PrP with reference to onset of scrapie in Suffolk and Corriedale sheep in JapanJournal of General Virology, 1995